Drug Profile
Research programme: VCAM-1 inhibitors - Pfizer
Alternative Names: CP 609643; CP 619700; CP 664511Latest Information Update: 05 Sep 2006
Price :
$50
*
At a glance
- Originator Pfizer
- Class Small molecules
- Mechanism of Action Immunosuppressants; Vascular cell adhesion molecule inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic asthma; Respiratory tract disorders
Most Recent Events
- 05 Sep 2006 Discontinued - Preclinical for Allergic asthma in USA (unspecified route)
- 05 Sep 2006 Discontinued - Preclinical for Respiratory tract disorders in USA (unspecified route)
- 31 Jan 2001 Preclinical trials in Allergic asthma in USA (unspecified route)